-
公开(公告)号:US20200095247A1
公开(公告)日:2020-03-26
申请号:US16695303
申请日:2019-11-26
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , Brian K. Whiteley , John L. Gilmore , Sreekantha Ratna Kumar , Laxman Pasunoori , Pitani Veera Venkata Srinivas , Srinivasan Kunchithapatham Duraisamy , Subramanya Hegde , Rushith Kumar Anumula
IPC分类号: C07D471/04 , C07D491/107 , C07D471/08 , A61P25/00 , A61P29/00 , A61P19/02 , C07D495/10 , C07D519/00 , A61P37/00
摘要: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20190185469A1
公开(公告)日:2019-06-20
申请号:US16222145
申请日:2018-12-17
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , Brian K. Whiteley , John L. Gilmore , Sreekantha Ratna Kumar , Laxman Pasunoori , Pitani Veera Venkata Srinivas , Srinivasan Kunchithapatham Duraisamy , Subramanya Hegde , Rushith Kumar Anumula
IPC分类号: C07D471/04 , C07D491/107 , C07D471/08 , C07D495/10 , A61P29/00 , A61P19/02 , A61P25/00
摘要: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20180325874A1
公开(公告)日:2018-11-15
申请号:US16042116
申请日:2018-07-23
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar
IPC分类号: A61K31/4196 , C07D249/00 , C07D471/04 , A61K31/4427 , A61K31/437 , A61K45/06
摘要: Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US11998537B2
公开(公告)日:2024-06-04
申请号:US17287735
申请日:2019-10-22
IPC分类号: A61K31/4545 , A61K47/54 , A61K47/55
CPC分类号: A61K31/4545 , A61K47/54 , A61K47/55
摘要: Disclosed are compounds of Formula (I) Formula (I) N-oxides, or salts thereof, wherein G1, G2, L, R1a, R1b, R4, R5, n, m, x, and y are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US11912703B2
公开(公告)日:2024-02-27
申请号:US17854089
申请日:2022-06-30
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Sreekantha Ratna Kumar , Durga Buchi Raju Barre , Srinivasan Kunchithapatham Duraisamy
IPC分类号: C07D471/04 , C07D519/00
CPC分类号: C07D471/04 , C07D519/00
摘要: Disclosed are compounds of Formula (I)
N-oxides, or salts thereof, wherein A, G, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.-
公开(公告)号:US20220348576A1
公开(公告)日:2022-11-03
申请号:US17854089
申请日:2022-06-30
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Sreekantha Ratna Kumar , Durga Buchi Raju Barre , Srinivasan Kunchithapatham Duraisamy
IPC分类号: C07D471/04 , C07D519/00
摘要: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein A, G, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20220340555A1
公开(公告)日:2022-10-27
申请号:US17245595
申请日:2021-04-30
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , Brian K. Whiteley , John L. Gilmore , Sreekantha Ratna Kumar , Laxman Pasunoori , Pitani Veera Venkata Srinivas , Srinivasan Kunchithapatham Duraisamy , Subramanya Hegde , Rushith Kumar Anumula
IPC分类号: C07D471/04 , A61P19/02 , A61P25/00 , C07D495/10 , C07D519/00 , C07D491/107 , A61P37/00 , C07D471/08 , A61P29/00
摘要: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20210253593A1
公开(公告)日:2021-08-19
申请号:US16763670
申请日:2018-11-13
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , John L. Gilmore , Tasir Shamsul Haque , Brian K. Whiteley , David R. Tortolani , Shoshana L. Posy , John E. Macor , Louis J. Lombardo , Ramesh Kumar Sistla , Anupama Kandhi Ramachandra Reddy , Subramanya Hegde , Laxman Pasunoori , Sreekantha Ratna Kumar
IPC分类号: C07D498/04 , C07D413/14 , C07D471/04 , C07D487/04 , C07D417/14 , C07D405/14 , C07D513/04 , C07D401/14 , C07D495/04
摘要: Disclosed are compounds of Formula (I) or salts thereof, wherein Ring Het, R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US11046646B2
公开(公告)日:2021-06-29
申请号:US16636670
申请日:2018-08-08
发明人: Alaric J. Dyckman , Ling Li , John L. Gilmore
IPC分类号: C07D207/04 , A61K31/40 , A61P1/00 , C07D207/16
摘要: Disclosed are compounds of Formula (I): (I) or a salt thereof, wherein: X is —CH2— or —C(O)—; R1 is —OH or —OP(O)(OH)2; L is a bond, —CH2—, or —C(O)—; R2 is n-C6-8 alkyl; each R3 is independently selected from Cl and —CH3; and n is zero, 1, or 2; provided that if X is —CH2—, then L is —CH2— or —C(O)—. Also disclosed are methods of using such compounds as selective agonists for G protein coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
-
公开(公告)号:US20210085651A1
公开(公告)日:2021-03-25
申请号:US17113495
申请日:2020-12-07
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
IPC分类号: A61K31/4196 , C07D249/00 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D471/04
摘要: Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
-
-
-
-
-
-
-
-